Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2007; 13(12): 1820-1823
Published online Mar 28, 2007. doi: 10.3748/wjg.v13.i12.1820
Published online Mar 28, 2007. doi: 10.3748/wjg.v13.i12.1820
Indication | Group 1(active drug) | Group 2(placebo) | Total |
Unexplained abdominal pain | 55 | 56 | 111 |
Suspected colonic tuberculosis | 14 | 12 | 26 |
Ulcerative colitis | 11 | 13 | 24 |
Hematochezia | 5 | 5 | 10 |
Fecal occult blood positive | 4 | 6 | 10 |
Colon cancer | 2 | 4 | 6 |
Occult gastrointestinal bleeding | 2 | 2 | 4 |
Colonic polyp | 1 | 2 | 3 |
Portal hypertension (colonic bleed) | 2 | 1 | 3 |
Crohn’s disease | 2 | 1 | 3 |
- Citation: Misra S, Dwivedi M. Role of intravenously administered hyoscine butyl bromide in retrograde terminal ileoscopy: A randomized, double-blinded, placebo-controlled trial. World J Gastroenterol 2007; 13(12): 1820-1823
- URL: https://www.wjgnet.com/1007-9327/full/v13/i12/1820.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i12.1820